---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-23-007072"
form_type: "8-K"
ticker: "PGEN"
cik: "0001356090"
company_name: "PRECIGEN, INC."
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T06:04:44.471141+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Precigen Q1 loss narrows to $22.7M; raises $72.8M in offering; pipeline advances

## Summary
- Revenue fell 66% YoY; Q1 operating loss $22.7M ($0.10 EPS) vs $23.9M ($0.12 EPS) in Q1 2022.
- Cash, equivalents and investments $125.4M; net proceeds of $72.8M from public offering at $1.75/share.
- Retired $29.5M of convertible notes; remaining $13.8M due July 2023 to be retired with restricted cash.
- Phase 1 PRGN-2012 data: 50% complete response; Phase 2 enrollment completed (N=23).
- First patient dosed with PRGN-3007 UltraCAR-T (PD-1 checkpoint); regained exclusive rights to CD19 and BCMA targets.

## SEC filing metadata
- accession: 0000950103-23-007072
- form_type: 8-K
- ticker: PGEN
- cik: 0001356090
- company_name: PRECIGEN, INC.
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356090/000095010323007072/0000950103-23-007072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356090/000095010323007072/dp193579_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-23-007072
- JSON: https://secwatch.observer/filing/0000950103-23-007072.json
- Plain text: https://secwatch.observer/filing/0000950103-23-007072.txt

## Key facts
- Earnings Releases
  PRECIGEN, INC. reported financial results for the quarter ended March 31, 2023.
  - Period: the quarter ended March 31, 2023
  - Result: reported results
  source text: Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated May 10, 2023, reporting its financial results for the quarter ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356090/000095010323007072/0000950103-23-007072-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.